APN 201302040015A
Cautionary announcement - discussions with MSD
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
CAUTIONARY ANNOUNCEMENT – DISCUSSIONS WITH MSD
Shareholders are advised that Aspen is currently engaged
in discussions with MSD (known as Merck in the United
States and Canada) in respect of a possible transaction
comprising the acquisition of an active pharmaceutical
ingredient facility situated primarily in the Netherlands
and a related portfolio of pharmaceutical finished dose
form products.
These discussions may have a material effect on the price
of Aspen's securities if successfully concluded and
accordingly shareholders are advised to exercise caution
when dealing in the company’s securities.
Durban
4 February 2013
Sponsor
Investec Bank Limited
Date: 04/02/2013 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
